Atea Pharmaceuticals (AVIR) Asset Utilization Ratio (2021)
Atea Pharmaceuticals (AVIR) posted quarterly Asset Utilization Ratio of 0.43 for Q4 2021.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Asset Utilization Ratio (2021) Analysis & Trends
Atea Pharmaceuticals' Asset Utilization Ratio history runs 1 years deep, the most recent figure standing at 0.43 for Q4 2021.
- In Q4 2021, Asset Utilization Ratio changed N/A year-over-year to 0.43; the TTM figure through Dec 2021 stood at 0.43 (changed N/A YoY), while the FY2021 annual figure was 0.43, up 291.02% from the prior year.
- Asset Utilization Ratio for Q4 2021 stood at 0.43.
- The five-year high for Asset Utilization Ratio was 0.43 in Q4 2021, with the low at 0.43 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Atea Pharmaceuticals | 467.50 Mn | 467.50 Mn | - | - |